Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-17-026942
Filing Date
2017-09-05
Accepted
2017-09-05 15:43:29
Documents
1
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4091
  Complete submission text file 0001127602-17-026942.txt   5463
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1929 BRASSFIELD ROAD RALEIGH NC 27614
Business Address
Barnes Alane P (Reporting) CIK: 0001584348 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 171068644